Skip to content

Comparison of hormonal response to a mixed-meal tolerance test after Laparoscopic Roux-en-Y gastric bypass versus Laparoscopic sleeve gastrectomy with duodenojejunal bypass in super morbidly obese patients: A prospective single-center non-inferiority randomized clinical trial

Comparison of hormonal response to a mixed-meal tolerance test after Laparoscopic Roux-en-Y gastric bypass versus Laparoscopic sleeve gastrectomy with duodenojejunal bypass in super morbidly obese patients: A prospective single-center non-inferiority randomized clinical trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260223008
Enrollment
32
Registered
2026-02-23
Start date
2024-08-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of hormonal response to a mixed-meal tolerance test after Laparoscopic Roux-en-Y gastric bypass versus Laparoscopic sleeve gastrectomy with duodenojejunal bypass in super morbidly obese patients. bariatric surgery, mixed-meal tolerance test, obesity

Interventions

Sleeve gastrectomy with duodenojejunal bypass is a surgical technique in which the greater curvature of the stomach is resected and separated from the lesser curvature and antrum, reducing the gastric
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Sleeve gastrectomy with duodenojejunal bypass,Roux-en-Y gastric bypass

Sponsors

The Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
Lead Sponsor
Thai Red Cross Soceity Fund (2025),The Thai Endocrine Society Research Grants (2024)
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with an indication for bariatric surgery 2. BMI 50-60 kg/m2 3. Patients who are motivated to lose weight but have not achieved successful weight reduction despite optimal medical therapy and exercise under physician supervision

Exclusion criteria

Exclusion criteria: 1. Patients with diabetes mellitus. 2. Patients with severe comorbid conditions that contraindicate surgery, such as advanced heart disease or chronic kidney failure. 3. Patients with a history of previous bariatric surgery. 4. Patients with gastroesophageal reflux disease refractory to medical therapy, large hiatal hernia, or endoscopic findings of reflux esophagitis grade C or D, or Barrett esophagus. 5. Patients with psychiatric disorders that impair eating behavior control. 6. Patients with a history of pancreatitis, pancreatic disease, or inflammatory bowel disease. 7. Patients who have used steroids or GLP-1 receptor agonists within the past 2 months.

Design outcomes

Primary

MeasureTime frame
Hormonal response Post-operative 6-24 months Mixed-meal tolerance test

Secondary

MeasureTime frame
Hypoglycemia Post-operative 6-24 months Mixed-meal tolerance test

Countries

Thailand

Contacts

Public ContactPrimploy Greeviroj

King Chulalongkorn Memorial Hospital

primploy.greeviroj@hotmail.com022564101

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026